Dr Ed Day MA BM BCh DM MRCPsych

Dr Ed Day

School of Psychology
Clinical Reader
Associate Professor in Psychiatry and Honorary Consultant Psychiatrist
Institute for Mental Health

Dr Ed Day is a Psychiatrist who combines clinical work in the NHS with research and teaching. He specializes in the treatment of drug and alcohol use disorders, and his research focuses on testing novel pharmacological and psychosocial interventions. He was appointed the National Recovery Champion by the Home Office in May 2019.

Learn more


MA, BM, BCh, DM, MRCPsych


Ed set up and ran an MSC program in the Treatment of Addictive Behaviours at the University of Birmingham between 2008 and 2012. He currently teaches about addictions-related issues on the DClinPsy, MBChB, and MPharm courses, and is developing a module on addictions and mental illness on the new Institute for Mental Health MSc program.

Postgraduate supervision

Treatment of alcohol or drug use disorders

Other activities

Executive member of the Society for the Study of Addiction (SSA) 2007-present, and currently the Vice-President.

Elected member of the Addictions Faculty at the Royal College of Psychiatry in 2018, and former Vice-Chair and Academic Secretary.

Appointed by the Home Office as the National Drug Recovery Champion in May 2019


Recent publications


Day, E, Manitsa, I, Farley, A & Kelly, JF 2024, 'The UK National Recovery Survey: nationally representative survey of people overcoming a drug or alcohol problem', BJPsych Open, vol. 10, no. 2, e67. https://doi.org/10.1192/bjo.2023.654

Day, E, Manitsa, I, Farley, A & Kelly, JF 2023, 'A UK national study of prevalence and correlates of adopting or not adopting a recovery identity among individuals who have overcome a drug or alcohol problem', Substance abuse treatment, prevention, and policy, vol. 18, no. 1, 68. https://doi.org/10.1186/s13011-023-00579-2

Metrebian, N, Carter, B, Eide, D, McDonald, R, Neale, J, Parkin, S, Dascal, T, Mackie, C, Day, E, Guterstam, J, Horsburgh, K, Kåberg, M, Kelleher, M, Smith, J, Thiesen, H & Strang, J 2023, 'A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS', BMC Public Health, vol. 23, no. 1, 1608. https://doi.org/10.1186/s12889-023-16445-6

Donoghue, K, Boniface, S, Brobbin, E, Byford, S, Coleman, R, Coulton, S, Day, E, Dhital, R, Farid, A, Hermann, L, Jordan, A, Kimergård, A, Koutsou, ML, Lingford-Hughes, A, Marsden, J, Neale, J, O'Neill, A, Phillips, T, Shearer, J, Sinclair, J, Smith, J, Strang, J, Weinman, J, Whittlesea, C, Widyaratna, K & Drummond, C 2023, 'Adjunctive Medication Management and Contingency Management to enhance adherence to acamprosate for alcohol dependence: the ADAM trial RCT', Health technology assessment (Winchester, England), vol. 27, no. 22, pp. 1-88. https://doi.org/10.3310/DQKL6124

Asquith, E, Bould, K, Catling, JC, Day, EJ & Holt, A 2023, 'Behaviour regulation and the role of mental health in non-alcoholic fatty liver disease', BMC Gastroenterology, vol. 23, no. 1, 306. https://doi.org/10.1186/s12876-023-02941-x

Sinclair, JMA, Aslan, B, Agabio, R, Anilkumar, A, Brosnan, M, Day, E, Dowling, NA, Flood, C, Grant, JE, Halliday, R, Hofvander, B, Howes, L, Moseley, R, Myers, B, O'Connor, V, Shaya, G, Thomas, S, Robinson, J & Chamberlain, SR 2023, 'Identifying the most important research, policy and practice questions for substance use, problematic alcohol use and behavioural addictions in autism (SABA-A): A priority setting partnership', Comprehensive Psychiatry, vol. 124, 152393. https://doi.org/10.1016/j.comppsych.2023.152393

Marsden, J, Kelleher, M, Gilvarry, E, Mitcheson, L, Bisla, J, Cape, A, Cowden, F, Day, E, Dewhurst, J, Evans, R, Hardy, W, Hearn, A, Kelly, J, Lowry, N, McCusker, M, Murphy, C, Murray, R, Myton, T, Quarshie, S, Vanderwaal, R, Wareham, A, Hughes, D & Hoare, Z 2023, 'Superiority and cost-effectiveness of monthly extended-release buprenorphine versus daily standard of care medication: a pragmatic, parallel-group, open-label, multicentre, randomised, controlled, phase 3 trial', EClinicalMedicine, vol. 66, 102311. https://doi.org/10.1016/j.eclinm.2023.102311

Shearer, J, Metrebian, N, Weaver, T, Goldsmith, K, Strang, J, Pilling, S, Mitcheson, L, Day, E, Dunn, J, Glasper, A, Akhtar, S, Bajaria, J, Charles, V, Desai, R, Haque, F, Little, N, McKechnie, H, Mosler, F, Mutz, J, Poovendran, D & Byford, S 2023, 'The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation', Value in Health, vol. 26, no. 5, pp. 658-665. https://doi.org/10.1016/j.jval.2022.11.021

McDonald, R, Eide, D, Abel-Ollo, K, Barnsdale, L, Carter, BR, Clausen, T, Day, E, Fonseca, F, Holmen, E, Horsburgh, K, Kelleher, M, Kaberg, M, Ladenhauf, M, McAuley, A, Metrebian, N, Neale, J, Parkin, S, Ratcliffe, K, Rintoul, C, Smith, J, Stifanoviciute, V, Torrens, M, Thiesen, H & Strang, J 2022, 'A rapid assessment of take-home naloxone provision during COVID-19 in Europe', International Journal of Drug Policy, vol. 107, 103787. https://doi.org/10.1016/j.drugpo.2022.103787

Holland, A, Stevens, A, Harris, M, Lewer, D, Sumnall, H, Stewart, D, Gilvarry, E, Wiseman, A, Howkins, J, McManus, J, Shorter, GW, Nicholls, J, Scott, J, Thomas, K, Reid, L, Day, E, Horsley, J, Measham, F, Rae, M, Fenton, K & Hickman, M 2022, 'Analysis of the UK Government's 10-Year Drugs Strategy-a resource for practitioners and policymakers', Journal of Public Health. https://doi.org/10.1093/pubmed/fdac114

Lowry, N, Cowden, F, Day, E, Gilvarry, E, Johnstone, S, Murray, R, Kelleher, M, Mitcheson, L & Marsden, J 2022, 'Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation', BMJ open, vol. 12, no. 10, e067194. https://doi.org/10.1136/bmjopen-2022-067194


Dhital, R, Coleman, R, Day, E, Drummond, C, Lingford-Hughes, A, Marsden, J, Phillips, T, Sinclair, J, Strang, J, Weinman, J, Whittlesea, C, Widyaratna, K & Donoghue, K 2022, 'Correction to: Service Users’ Views and Experiences of Alcohol Relapse Prevention Treatment and Adherence: New Role for Pharmacists? ', Alcohol and Alcoholism, vol. 57, no. 5, pp. 642-642. https://doi.org/10.1093/alcalc/agac016


Humphreys, K, Calder, R, Marsden, J & Day, E 2023, 'How Addiction handles disagreements over potentially harmful terminology', Addiction, vol. 118, no. 10, pp. 1833-1834. https://doi.org/10.1111/add.16302


Kuningas, K, Driscoll, J, Mair, R, Day, E & Sharif, A 2023, 'Short-term Healthy Lifestyle Intervention and Long-term Behavior Change After Kidney Transplantation: Findings From the CAVIAR Study', American Journal of Kidney Diseases, vol. 81, no. 2, pp. 249-252. https://doi.org/10.1053/j.ajkd.2022.08.020

Review article

Boden, M & Day, E 2023, 'Illicit drug use in university students in the UK and Ireland: a PRISMA-guided scoping review', Substance abuse treatment, prevention, and policy, vol. 18, no. 1, 18. https://doi.org/10.1186/s13011-023-00526-1

View all publications in research portal